Print Page | Close Window

News Release

Printer Friendly Version View printer-friendly version
<< Back
Valeant Pharmaceuticals to Present at Cowen and Company 30th Annual Health Care Conference
ALISO VIEJO, Calif., March 2, 2010 /PRNewswire via COMTEX/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced that J. Michael Pearson, the Company's chairman and chief executive officer, will make a presentation at the Cowen and Company 30th Annual Health Care Conference on Tuesday, March 9, 2010 at 3:00 p.m. ET. The conference will be held at the Boston Marriott Copley Place in Boston, MA.

A live webcast and audio archive of the presentation will be available on the company's Web site at http://www.valeant.com/. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. The webcast also can be accessed through the following URL:

http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=VRX&item_id=2755407

About Valeant

Valeant Pharmaceuticals International (NYSE: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at www.valeant.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081125/VALEANTLOGO)

Contact:
Laurie Little
Valeant Pharmaceuticals
949-461-6002

SOURCE Valeant Pharmaceuticals International